Despite the success of lung transplantation, infection is one of the leading causes of
morbidity and mortality. Mycobacterial infections have been reported rarely, with the majority …

Background Immunosuppression and chronic lung disease are known risk factors for
mycobacterial infection and might be expected to develop with an increased frequency in …

Background Pulmonary non-tuberculous mycobacterial (NTM) infection is relatively common
after lung transplantation, but the effect on mortality remains undetermined. Herein we …

Background The incidence of infection with non‐tuberculous mycobacteria (NTM) after lung
transplant is insufficiently defined. Data on the impact of NTM infection on lung transplant …

Purpose Non‐tuberculous mycobacteria (NTM) are important pathogens in lung transplant
recipients. This study describes the spectrum of NTM respiratory tract infections and …

Infections have been and still are the major cause of morbidity and mortality after lung
transplantation. Nevertheless, the negative impact of infection on outcome has lessened …

With the availability of advanced microbiologic techniques for the detection and identification
of nontuberculosis mycobacteria (NTM) over the last 10 years, the number of NTM species …

Mycobacterial infections in the transplant recipient differ considerably from those occurring
in the normal host. The incidences of active disease, atypical disease, and extrapulmonary …

The diagnosis and treatment of Mycobacterium tuberculosis, although difficult in normal
hosts, are even more complex in transplant recipients. As a result of the use of …

Non-tuberculous mycobacteria are ubiquitous environmental organisms that are now
increasingly recognized as important causes of clinical disease in solid organ transplant …